Stockhead on MSN12h
Paradigm closer to phase III clinical trial with appointment of preferred CRO
Paradigm Biopharmaceuticals continues to edge closer towards starting the pivotal phase III trial for its knee osteoarthritis ...
manilatimes1h
HCW Biologics Granted FDA Clearance to Evaluate One of the Company's Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial
This study will evaluate HCW9302 in patients with moderate to severe alopecia areata. MIRAMAR, Fla., Feb. 03, 2025 (GLOBE ...